Domestic-only oncology NAS launches (cumulative)
Number of oncology novel active substances launched only in their domestic market, with no launch in other markets, over a stated period.
Unit Count Industry Healthcare
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Domestic-only oncology NAS launches (cumulative)
China, 2020–2024
Every record
All records
1 record · 1 region · 2020–2024
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global Oncology Trends 2025 | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Domestic-only oncology NAS launches (cumulative). Retrieved from https://statorigin.org/indicators/domestic-only-oncology-nas-launches-cumulative